The structure of protein RAF1 revealed: A key step in the development of new drugs against lung cancer
How the gut may help to drive COVID-19
1 September 2022What you need to know about bivalent boosters for COVID-19
1 September 2022The structure of protein RAF1 revealed: A key step in the development of new drugs against lung cancer
One of the main challenges in oncology is the development of drugs against KRAS oncogenes. These oncogenes—genes that cause cancer when mutated—are responsible for a quarter of all human cancers, including the three tumor types with the highest mortality rates: lung adenocarcinoma, colorectal carcinoma and pancreatic ductal adenocarcinoma.
